Investor relations
The purpose of Gradientech’s Investor Relations is to continuously inform the capital market about the company’s operations and development. Here you will find press releases and financial reports as well as information about the share and corporate governance. You can also receive all our press releases to your email as soon as we post them. Just click the button below and fill in your email in the form and approve the confirmation email sent back to you. It is just as easy to unsubscribe whenever you want. Welcome!
Annual report 2024
Here you can read about significant events during the year, our target market and the strategy going forward.
AGM 2025
The Annual General Meeting was held on 21 May 21 2025. Here you can find all documentation from the AGM.
Keep up to date - subscribe
About Gradientech
Gradientech is leading the field of ultra-rapid antibiotic susceptibility testing. We develop next-generation diagnostics that provide patients with the right dose of the right medicine at the right time.